The Flowr Corp., a Canadian licensed producer that focuses
primarily on premium flower production, was recently highlighted in a Bloomberg
article titled, “Scotts Miracle-Gro Tests Whether It Can Make Pot Grow Too,”
authored by Kristine Owram. Per the article, Scotts Miracle-Gro Company’s
(NYSE: SMG) subsidiary, Hawthorne Gardening Co., is partnering up with Flowr to
build a 50,000-square-foot research facility on the same site as Flowr’s grow-op
in Kelowna, British Columbia. Firstly, the new lab will test Hawthorne’s lights
and nutrients on cannabis, with plans to ultimately conduct more in-depth
studies on the plant.
Currently producing 250 grams a square foot at its grow-op,
Flowr seeks to nearly double that number to produce some of the highest crop
yields in the industry, targeting an ultimate yield of 450 grams. The company
has already inked supply agreements with the Ontario and B.C. governments ahead
of legalization and has secured a distribution agreement to sell medical
marijuana in Germany next year. Presently, the company’s seasoned executives
are eyeing opportunities in the Caribbean and South America. The president and
co-founder of Flowr, Tom Flow, was also the co-founder of MedReleaf Corp., a
company recently acquired by Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) for
roughly $2.2 billion in stock. Flow also brought several of the MedReleaf team
members to Flowr, which is set to list on the TSX Venture Exchange next month
via a reverse takeover.
To view the full article, visit http://ibn.fm/Q7APK
About The Flowr Corp.
The Flowr Group (Okanagan) Inc., through its subsidiaries,
is a vertically-integrated Canadian cannabis company focused on the natural
science of cannabis. With head offices in Markham, ON and production in
Kelowna, BC, Flowr builds and operates large-scale, GMP compliant cultivation
facilities utilizing its own patented growing systems. Flowr’s investment in
research and development ensures that its master growers are able to supply
patients with consistent, high-quality medicinal cannabis. With a sense of
craftsmanship and a spirit of innovation, Flowr is also well positioned with a
line of premium quality cannabis products for the upcoming adult-use market.
Flowr recently signed a Memorandum of Understanding to supply premium cannabis
to the British Columbia Liquor Distribution Board which will be the sole
retailer of non-medicinal cannabis in the province following the October 17
legalization of adult recreational consumption. The company announced earlier
in the year that it had been selected by the Hawthorne Canada subsidiary of The
Scotts Miracle-Gro Company for an exclusive strategic R&D alliance. Flowr
also has announced its intention to list shares on the TSX Ventures Exchange.
For more information, visit the company’s website at www.flowrco.ca.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment